John Buckingham appeared on CNBC on May 10, 2016. John likes biotech stocks like Gilead and Amgen because they are trading at attractive valuations. If Hillary comes to power we will see what happens with the possibility of price controls and increased regulation. John already owns a sufficient … Read more about Pro: Impossible to successfully time the market